2015-04-10 Call Buyers Look For New Highs In Omnicare Soon (OCR)
Call Buyers Look For New Highs In Omnicare Soon (OCR)
Notes: On February 25th, Omnicare reported Q4 EPS of $0.96 (beat estimates by a penny) on revenue of $1.63B vs the $1.61B Wall Street estimate (6% year over year increase). The Specialty Care Group segment is driving the growth as sales jumped 21% to $443M in the fourth quarter (third straight quarter of high double digit growth). Shares of the $7.6B healthcare services company trade at a P/E ratio of 18.85x (2015 estimates), price to sales ratio of 1.17x, and a price to book ratio of 2.94x. Earnings are projected to grow in the low double digit range and sales in the mid-single digit range annually this year and in 2016. Following the latest quarterly report (Q1 earnings out on April 29th), Cowen raised their price target to $84 from $76 on February 26th and RBC Capital upped their target to $82 from $76 on March 13th.
Omnicare (OCR) Options Trade Idea
Buy the (OCR) May $80/$85 bull call spread for a $1.50 debit or better
(Buy the May $80 call and sell the May $85 call, all in one trade)
Stop loss- None
1st upside target- $3.00
2nd upside target- $4.50
Additional notes: This becomes a higher probability trade if you wait for the technical confirmation (see the chart above), but fundamental story and recent bullish options activity are reason to consider getting long Omnicare.
ORM Market Commentary (5-10 trades/analysis of stocks, ETFs, and indices like in the Free Trade of the Day above) is included in my ORM Equity/Option Trader Subscription Service for $9.99 per month (available now!).
1 On 1 Options Mentoring: Learn more about my 1 on 1 equity/options mentoring courses that help can you improve your trading odds and risk management skills (courses start as low as $55!).